Literature DB >> 23535011

Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children.

Paola Giordano1, Gennaro M Lenato, Patrizia Suppressa, Patrizia Lastella, Franca Dicuonzo, Luigi Chiumarulo, Maria Sangerardi, Paola Piccarreta, Raffaella Valerio, Arnaldo Scardapane, Giuseppe Marano, Nicoletta Resta, Nicola Quaranta, Carlo Sabbà.   

Abstract

OBJECTIVE: To evaluate the clinical features in a large cohort of pediatric patients with genetically confirmed hereditary hemorrhagic telangiectasia (HHT) and to identify possible predictors of arteriovenous malformation (AVM) onset or clinical significance. STUDY
DESIGN: Prospective cross-sectional survey of all children subjected to screening for AVMs in the multidisciplinary HHT center. All patients proved to be carriers of endoglin mutations or activin A receptor type-II-like kinase 1 mutations, defined as HHT1 and HHT2, respectively. A full clinical-radiological protocol for AVM detection was adopted, independent from presence or absence of AVM-related symptoms.
RESULTS: Forty-four children (mean age, 10.3 years; range, 1-18) were subjected to a comprehensive clinical-radiologic evaluation. This investigation disclosed cerebrovascular malformations in 7 of 44 cases, pulmonary AVMs in 20 of 44 cases, and liver AVMs in 23 of 44 cases. Large visceral AVMs were found in 12 of 44 children and were significantly more frequent in patients with HHT1. Only large AVMs were associated with symptoms and complications.
CONCLUSIONS: Children with HHT have a high prevalence of AVMs; therefore, an appropriate clinical and radiological screening protocol is advisable. Large AVMs can be associated with complications in childhood, whereas small AVMs probably have no clinical risk.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23535011     DOI: 10.1016/j.jpeds.2013.02.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Angioarchitecture of Hereditary Arteriovenous Malformations.

Authors:  Patricia E Burrows
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

2.  A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report.

Authors:  Ahmad R Khan; Salma Waqar; Muhammad Hayyan Wazir; Amina Arif
Journal:  Cureus       Date:  2022-04-27

3.  Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?

Authors:  Giuseppe A Latino; Dale Brown; Richard H Glazier; Jonathan T Weyman; Marie E Faughnan
Journal:  Orphanet J Rare Dis       Date:  2014-07-25       Impact factor: 4.123

4.  Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.

Authors:  E M de Gussem; C P Edwards; A E Hosman; C J J Westermann; R J Snijder; M E Faughnan; J J Mager
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

5.  European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Omer F Eker; Edoardo Boccardi; Ulrich Sure; Maneesh C Patel; Saverio Alicante; Ali Alsafi; Nicola Coote; Freya Droege; Olivier Dupuis; Annette Dam Fialla; Bryony Jones; Ujwal Kariholu; Anette D Kjeldsen; David Lefroy; Gennaro M Lenato; Hans Jurgen Mager; Guido Manfredi; Troels H Nielsen; Fabio Pagella; Marco C Post; Catherine Rennie; Carlo Sabbà; Patrizia Suppressa; Pernille M Toerring; Sara Ugolini; Elisabetta Buscarini; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

6.  Comorbidity among HHT patients and their controls in a 20 years follow-up period.

Authors:  Katrine Saldern Aagaard; Anette Drøhse Kjeldsen; Pernille Mathiesen Tørring; Anders Green
Journal:  Orphanet J Rare Dis       Date:  2018-12-14       Impact factor: 4.123

7.  Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study.

Authors:  Katie L Mowers; Lynn Sekarski; Andrew J White; R Mark Grady
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

8.  Hereditary hemorrhagic telangiectasia presenting as a recurrent epistaxis in an adolescent: A case report.

Authors:  Ratna Acharya; Katherin Portwood; Kiran Upadhyay
Journal:  World J Clin Pediatr       Date:  2021-01-09

9.  Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report.

Authors:  Fabio E Ospina; Alex Echeverri; Iván Posso-Osorio; Lina Jaimes; Jaiber Gutierrez; Gabriel J Tobón
Journal:  Colomb Med (Cali)       Date:  2017-06-30

10.  Genotype-Phenotype Correlations in Children with HHT.

Authors:  Alexandra Kilian; Giuseppe A Latino; Andrew J White; Dewi Clark; Murali M Chakinala; Felix Ratjen; Jamie McDonald; Kevin Whitehead; James R Gossage; Doris Lin; Katharine Henderson; Jeffrey Pollak; Justin P McWilliams; Helen Kim; Michael T Lawton; Marie E Faughnan
Journal:  J Clin Med       Date:  2020-08-22       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.